Global Montelukast Sodium Market Strategic Research Report

Scope of the Report

The global Montelukast Sodium market size is predicted to grow from US$ 66.52 million in 2025 to US$ 150 million in 2032; it is expected to grow at a CAGR of 13.5% from 2026 to 2032.

Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.In 2024, global Montelukast Sodium production reached approximately 122 MT, with an average global market price of around US$ 562 per kg.

Montelukast sodium demand is mainly driven by the large and persistent patient base for asthma control, exercise-induced bronchoconstriction prevention, and allergic rhinitis, plus the product’s “system” advantages: it’s oral, convenient for long-term use (including pediatric chewables/granules), and often positioned as add-on therapy when inhaled regimens don’t fully control symptoms or when adherence to inhalers is an issue. Because it is widely generic, volume is also shaped by payer formularies and tendering, seasonal allergy cycles, and growth in emerging markets; at the same time, utilization can be pressured by safety-risk communication around neuropsychiatric events (especially for mild allergic rhinitis), and by competition from inhaled corticosteroid/combination inhalers, inexpensive OTC allergy options, and (for severe asthma) biologics that can reduce reliance on oral add-ons.

Upstream, the montelukast sodium “market” is anchored in the API supply chain and its chemical building blocks: production relies on multi-step synthesis using specialty aromatic/heteroaromatic intermediates (quinoline-type cores and substituted phenyl side chains), sulfur-containing reagents for thioether construction, bases/acids for couplings and workups, and then salt formation to the sodium form (typically using sodium bases and tightly controlled crystallization/isolation). Costs and availability are therefore influenced by upstream petrochemical aromatics (benzene/toluene/xylene derivatives feeding advanced intermediates), chlorinating/activating reagents, catalysts, and large volumes of solvents and utilities, as well as by GMP-grade raw-material qualification, impurity controls (including “special attention” impurity classes such as nitrosamines where applicable), solvent recovery capacity, and hazardous-waste treatment economics. Downstream from API, finished-dose manufacturers pull on upstream markets for excipients (binders, disintegrants, coatings, sweeteners/flavors for pediatric forms) and packaging (blister films/foils, bottles), and the overall chain is highly sensitive to regulatory compliance, site approvals, and supply reliability because switching sources can require re-qualification.

As a mature, highly competitive generic small-molecule, the industry typically runs at mid-teens to mid-20% gross margins at the API level

Key Questions Addressed in this Report

What is the 10-year outlook for the global Montelukast Sodium market?

What factors are driving Montelukast Sodium market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Montelukast Sodium market opportunities vary by end market size?

How does Montelukast Sodium break out by Type, by Application?

This report presents a comprehensive overview of the global Montelukast Sodium market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Montelukast Sodium Amorphous
• Montelukast Sodium Crystalline

Segment by Feature

• Dodecyl Alcohol High-pressure Process
• Dodecyl Chloride Process

Segment by Channel

• Direct Selling
• Distribution

Segment by Application

• Asthma
• Allergic Rhinitis
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Montelukast Sodium market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Asthma, Allergic Rhinitis, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact